| Pedro Jimenez Valdes, MD | |
|
2741 Debarr Rd, Ste C-416, Anchorage, AK 99508-2953 | |
| (907) 258-4430 | |
| (907) 258-4435 |
| Full Name | Pedro Jimenez Valdes |
|---|---|
| Gender | Male |
| Speciality | Thoracic Surgery (cardiothoracic Vascular Surgery) |
| Location | 2741 Debarr Rd, Anchorage, Alaska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053396838 | NPI | - | NPPES |
| MD1611 | Medicaid | AK | |
| DC1725 | Other | RAILROAD MEDICARE | |
| 0000WFBKK | Other | MCARE ACS GRP |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | 3443 (Alaska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Pedro Jimenez Valdes, MD Po Box 84564, Seattle, WA 98124-5864 Ph: (907) 258-4430 | Pedro Jimenez Valdes, MD 2741 Debarr Rd, Ste C-416, Anchorage, AK 99508-2953 Ph: (907) 258-4430 |
News Archive
How much notice is required if benefits change? Do insurers have to give you a heads up if your plan doesn't meet the minimum coverage standard under the Affordable Care Act? Readers' questions this month are centered around insurance notification requirements.
New research has found alcohol use disorders to be one of the most vital avoidable risk factors for the onset of all types of dementia, early-onset dementia in particular.
Research efforts associating scientists from the CNRS, UVSQ and INSERM within the Laboratoire END-ICAP, working in collaboration with a team from the University of Bern, has demonstrated the therapeutic potential of a new class of synthetic oligonucleotides in the treatment of Duchenne muscular dystrophy (DMD) using RNA "surgery".
As former Surgeon General C. Everett Koop, M.D. once said, "Drugs don't work in patients who don't take them." That's why CIGNA is introducing CoachRx, an interactive Web site to help CIGNA Home Delivery Pharmacy customers identify their personal barriers to taking their medications, and then providing ways to help people stay on track with the medications they need.
The U.S. Food and Drug Administration today approved Afinitor (everolimus) for use in combination with Aromasin (exemestane) to treat certain postmenopausal women with advanced hormone-receptor positive, HER2-negative breast cancer.
› Verified 9 days ago
William E Curtis, MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 3851 Piper St, Ste U-264, Anchorage, AK 99508 Phone: 907-334-6442 Fax: 907-334-3302 | |
Mrs. Kerry J Tintzman, ANP Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Medicare Enrolled Practice Location: 2741 Debarr Rd, Ste C-416, Anchorage, AK 99508 Phone: 907-258-4430 Fax: 907-258-4435 | |
Kenton Edgar Stephens Jr., MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 2751 Debarr Rd Ste B320, Anchorage, AK 99508 Phone: 907-375-2000 Fax: 907-375-5558 | |
John Charles Dugal Jr., MD Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 2751 Debarr Rd Ste B320, Anchorage, AK 99508 Phone: 907-375-2000 |